Search | IOVS | ARVO Journals

Access Provided By:
MIT Libraries

Forgot password?

Create an Account

View

Showing 1 – 5 of 5

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2023

Development of a Prime Editing Strategy to Treat Mutations in the Crumbs Homologue 1 ( CRB1 ) Gene

Bruna Lopes Costa; Alexander A. Sousa; Yi-Ting Tsai; Yao Li; Irene H. Maumenee; David R. Liu; Stephen H. Tsang; Peter M.J. Quinn

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):3862.

ARVO Annual Meeting Abstract June 2023

Prime Editing Rescues Aberrant Splicing Defect Caused by Pathogenic Variants in PRPH2

Peter M.J. Quinn; Yi-Ting Tsai; Salvatore Marco Caruso; Siyuan Liu; Yao Li; Stephen H. Tsang; Bruna Lopes da Costa

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):3860.

ARVO Annual Meeting Abstract June 2023

Development of a Gene Augmentation Strategy for CRB1 -mediated Inherited Retinal Diseases

Joel Alan Imventarza; Keith Theodore; Bruna Lopes da Costa; Salvatore Marco Caruso; Stephen H. Tsang; Yi-Ting Tsai; Peter M.J. Quinn

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):3843.

ARVO Annual Meeting Abstract June 2017

Gene therapy refutes non-autonomous rod cell death in a preclinical model of retinitis pigmentosa

Susanne Friederike Koch; Jimmy Duong; Chun Wei Hsu; Yi-Ting Tsai; Chyuan-Sheng Lin; Stephen Tsang

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1574.

ARVO Annual Meeting Abstract April 2014

Gene therapy on patient-specific stem cell lines with MFRP defect

Yao Li; Wen-Hsuan Wu; Yi-Ting Tsai; Haiqing Hua; Takayuki Nagasaki; Irene H Maumenee; Lawrence A Yannuzzi; Quan V Hoang; Dieter Egli; Stephen H Tsang

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):834.

Advertisement